Shada AlSalamah | Drug Development Lifecycle | Best Researcher Award

Prof. Shada AlSalamah | Drug Development Lifecycle | Best Researcher Award

Associate Professor of Global Digital Health at King Saud University, Saudi Arabia.

Prof. Dr. Shada AlSalamah is a globally recognized thought leader in digital health, information security, and artificial intelligence. She currently serves as an Associate Professor in the Information Systems Department at King Saud University (KSU) and as a Technical Officer in Digital Health and AI at the World Health Organization (WHO) in Geneva. With an impressive career spanning over a decade in academia, policymaking, and digital innovation, she is at the forefront of integrating blockchain, cybersecurity, and AI into global healthcare systems. Her influence spans advisory roles at the OECD, MIT, and the European Commission, making her a leading voice in shaping the future of trustworthy health technologies.

Professional Profile

Scopus

Orcid

Google Scholar

Education 🎓📚

  • Ph.D. in Computer Science (Information Security in Healthcare Information Systems)
    Cardiff University, UK (2009–2015)
    Awarded: HRH Saudi Ambassador Scientific Excellence Award

  • M.Sc. in Strategic Information Systems with Information Assurance
    Cardiff University, UK (2008–2009)
    Awarded with Merit

  • B.Sc. in Information Technology
    King Saud University (KSU), Riyadh, Saudi Arabia (2002–2007)

Professional Experience 🧑‍🏫💼

Prof. AlSalamah’s professional journey reflects her strategic leadership across both academic and global health governance platforms. She joined KSU in 2017, advancing from Assistant to Associate Professor, and led key initiatives in cybersecurity and AI within the Center of Excellence in Information Assurance. At WHO, she played a pivotal role in developing digital health strategies and standards, contributing to critical projects on AI governance, algorithm auditing, and health data interoperability. Beyond WHO, she served as a consultant for Saudi Arabia’s Ministry of Health and the National Health Information Center, ensuring secure and effective implementation of digital health technologies. Her international engagement includes prestigious advisory board memberships at the OECD, theDevMaster (USA), and the International Association for Trusted Blockchain Applications (EU Commission).

Research Interest 🔬📈

  • Digital Health & AI Governance

  • Information Security in Healthcare

  • Blockchain in Clinical Systems

  • Health Data Interoperability

  • Cybersecurity Policy and Infrastructure

  • Algorithm Auditing & Machine Learning for Health

  • Cloud Security & Resource Allocation

🏆 Honors and Achievements

  • MIT linQ – IDEA² Global Fellow (2019)

  • Health Hackathon 1st Place Winner, KSU Innovation Center (2019)

  • IEEE Blockchain Challenge 2nd Place, Orlando, FL (2018)

  • Research Fellowship, ARAMCO/MIT IbnKhaldun Program

  • CSC Fellowship, Cardiff University Poster Awards (2x Best Poster)

  • Multiple Excellence Awards from HRH Saudi Ambassador (PhD Years 2011, 2013, 2014)

Publications Top Noted

  • Machine learning for health: algorithm auditing & quality control, J Med Systems (2021) — 61 citations

  • Healthybroker: A trustworthy blockchain-based eHealth broker, Electronics (2019) — 60 citations

  • Secondary data for global health digitalisation, Lancet Digital Health (2023) — 52 citations

  • QoS-aware GA for cloud resource allocation, UMT Conference (2017) — 34 citations

  • Emerging digital tech in healthcare with cybersecurity spotlight, Information (2023) — 33 citations

Conclusion 🌟🎯

Prof. Dr. Shada AlSalamah is an exceptional and deserving candidate for the Best Researcher Award, particularly in the context of the Digital Transformation of the Drug Development Lifecycle. Her global leadership in AI, blockchain, and cybersecurity in health represents a critical layer of innovation that supports the integrity, speed, and safety of modern pharmaceutical R&D.

Although her core work is more infrastructure- and policy-oriented than molecule-to-market, her influence enables trusted, secure, and ethical digital ecosystems upon which scalable drug innovation relies.

Ms. Jing Jing | Bioinformatics Awards | Best Researcher Award

Ms. Jing Jing | Bioinformatics Awards | Best Researcher Award

Ms. Jing Jing, Qufu Normal University, China

Ms. Jing Jing is a dedicated graduate student in Computer Science at Qufu Normal University, China, where she also earned her B.S. in Computer Science. Her research focuses on pattern recognition, spatial transcriptomics, and bioinformatics, where she applies computational tools to manage and analyze complex biological data. Through her work, Ms. Jing is contributing to the emerging intersection of spatial information and gene expression, advancing the field of bioinformatics with innovative research.

Professional Profile:

Scopus

Suitability for the Award

Ms. Jing Jing is at an early stage in her research career but has already made notable contributions to the fields of pattern recognition, spatial transcriptomics, and bioinformatics. Here’s an assessment of her suitability for the Best Researcher Award:

  1. Research Focus on Emerging Fields:

    • Her work in spatial transcriptomics and bioinformatics positions her at the forefront of an emerging and highly specialized field. Spatial transcriptomics, which integrates spatial and genetic information, represents a promising area with significant potential for advancing our understanding of complex biological processes.
  2. Contributions to Scientific Knowledge:

    • Despite being in the early stages of her academic career, Ms. Jing Jing has already contributed to the scientific community through her publications. Her work on a multi-view contrastive fusion method demonstrates her ability to develop innovative solutions in bioinformatics.
  3. Academic Potential:

    • While her current citation count may be low, this is not unusual for a researcher at her stage. The importance and relevance of her research, particularly in spatial transcriptomics, suggest that her work is likely to gain recognition as the field continues to develop.
  4. Promise as a Future Leader in Research:

    • Ms. Jing Jing’s involvement in cutting-edge research areas such as spatial transcriptomics indicates strong potential for future contributions to the scientific community. Her current work lays a solid foundation for a promising research career.

Summary of Qualifications

  1. Education:

    • B.S. in Computer Science (2022), Qufu Normal University, Rizhao, China.
    • Currently pursuing a Master’s degree at the same institution, focusing on Computer Science.
  2. Research Focus:

    • Pattern Recognition.
    • Spatial Transcriptomics: An emerging field that combines spatial information with gene expression data.
    • Bioinformatics: The application of computational tools to manage, analyze, and interpret biological data.
  3. Publications:

    • “A review of recent advances in spatially resolved transcriptomics data analysis” (2024, Neurocomputing):
      • Co-authored a review article focusing on advances in spatially resolved transcriptomics, a cutting-edge area in bioinformatics.
    • “stMCFN: A Multi-view Contrastive Fusion Method for Spatial Domain Identification in Spatial Transcriptomics” (2024, Lecture Notes in Computer Science):
      • Contributed to the development of a novel multi-view contrastive fusion method aimed at improving spatial domain identification in spatial transcriptomics.
  4. Research Contributions:

    • Ms. Jing Jing has co-authored two significant publications, one of which reviews recent advancements in spatial transcriptomics data analysis, while the other proposes a new method for spatial domain identification in spatial transcriptomics.

Conclusion

While Ms. Jing Jing is still in the early stages of her research career, her focus on emerging and impactful fields such as spatial transcriptomics and bioinformatics makes her a promising candidate for future recognition. However, given the typically high standards of the Best Researcher Award, which often rewards more established researchers with significant citations and broader impact, Ms. Jing Jing might be better suited for awards or recognitions targeting early-career researchers or rising stars in the field. Her current trajectory suggests strong potential for future accomplishments that could make her a contender for more prestigious awards as she continues to develop her research portfolio.